Funding for this research was provided by:
Muscular Dystrophy Association (606383)
FSH Society (FSHS-82016)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR062587)
Received: 10 March 2022
Accepted: 26 April 2022
First Online: 10 May 2022
: All human cells and biopsies were anonymized prior to our receipt with no personal identifying information available to us. In addition, the cells and biopsies had been produced prior to our study and had been collected under protocols approved by the appropriate institution that included informed donor consent and approval to publish results in accordance with standards of the Helsinki Declaration. Because our studies were of human materials that were obtained from biobanks and for which personal identification data were not obtainable by us, the studies were classified as exempt from Human Studies review by the Boston University Institutional Review Board in accordance with US Department of Heath and Human Services policy.
: Not applicable.
: Authors declare no conflicts of interest.